Total Funding
6
Total FundingSeries D raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
316307
Crescendo Bioscience develops diagnostic tools to provide rheumatologists with clinical insights to autoimmune and inflammatory disease.
Acquired by 
Myriad Genetics
Eric Sasso: Vice President, Medical and Scientific AffairsPast Role: McGill University, Tranee- David Chernoff: Senior Vice President, Medical AffairsPast Role: CardioDx, Chief Medical Officer
About the Company
Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as
Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.
